David L. Williamson IV, Ph.D.

Assistant Professor of Kinesiology, School of Behavioral Sciences and Education
Health Education Graduate Faculty
Office Phone: +1 717 948 6539
Office Location: Educational Activities, 0202
Mailing Address:

Bottom Fields


Dr. David Williamson’s research seeks to delineate mechanisms that regulate aberrant growth signaling that contribute to skeletal muscle anabolic resistance in type 2 diabetes, obesity, and aging. Given his graduate training in human muscle physiology at the Human Performance Laboratory at Ball State, he expanded my knowledge of muscle physiology during his post-doctoral training at Hershey Medical Center by employing animal and cell models. In doing so, he studied how AMPK activation alters mTOR and mRNA translation in physiological contexts. Then arriving at West Virginia University, he further sought to determine how altered states of AMPK and/or mTOR activation would influence muscle differentiation and/or growth, using cell and mouse models of obesity and aging. Then at the University at Buffalo his laboratory focused on aberrant regulation of mTOR during aging and obesity, establishing the role of the mTOR inhibitor, REDD1, on the development of an anabolic resistant skeletal muscle phenotype. This mechanism may contribute to skeletal muscle cachexia in numerous models, such as type 2 diabetes, obesity, aging, cancer, and muscular dystrophy.

Research Interests
Mechanisms of skeletal muscle anabolic resistance
Interventions that improve insulin sensitivity
Mechanisms of exercise-induced insulin sensitivity